GB0605544D0 - Genetic Markers For Alzheimer Disease - Google Patents

Genetic Markers For Alzheimer Disease

Info

Publication number
GB0605544D0
GB0605544D0 GB0605544A GB0605544A GB0605544D0 GB 0605544 D0 GB0605544 D0 GB 0605544D0 GB 0605544 A GB0605544 A GB 0605544A GB 0605544 A GB0605544 A GB 0605544A GB 0605544 D0 GB0605544 D0 GB 0605544D0
Authority
GB
United Kingdom
Prior art keywords
genetic markers
alzheimer disease
sample
subject
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0605544A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Nottingham
Original Assignee
University of Nottingham
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Nottingham filed Critical University of Nottingham
Priority to GB0605544A priority Critical patent/GB0605544D0/en
Publication of GB0605544D0 publication Critical patent/GB0605544D0/en
Priority to PCT/GB2007/050111 priority patent/WO2007107785A2/en
Ceased legal-status Critical Current

Links

Abstract

The invention provides a method of identifying the existence of, or susceptibility to, neurodegenerative disorder in a subject. The method comprising:- (i) obtaining a sample from a subject; and (ii) detecting, in the sample, the presence of a genetic polymorphism in intron 2 of alpha-1-antichymotrypsin (ACT) gene, wherein the polymorphism is associated with neurodegenerative disorder. The invention also provides a kit for carrying out the method, methods of treatment, and medical uses of nucleic acids harbouring polymorphisms in the ACT gene and of peptides encoded thereby.
GB0605544A 2006-03-20 2006-03-20 Genetic Markers For Alzheimer Disease Ceased GB0605544D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB0605544A GB0605544D0 (en) 2006-03-20 2006-03-20 Genetic Markers For Alzheimer Disease
PCT/GB2007/050111 WO2007107785A2 (en) 2006-03-20 2007-03-08 Genetic markers in the alpha-1-antichymotrypsin (act) gene

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0605544A GB0605544D0 (en) 2006-03-20 2006-03-20 Genetic Markers For Alzheimer Disease

Publications (1)

Publication Number Publication Date
GB0605544D0 true GB0605544D0 (en) 2006-04-26

Family

ID=36293084

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0605544A Ceased GB0605544D0 (en) 2006-03-20 2006-03-20 Genetic Markers For Alzheimer Disease

Country Status (2)

Country Link
GB (1) GB0605544D0 (en)
WO (1) WO2007107785A2 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2138177A1 (en) * 2000-03-03 2009-12-30 Eisai R&D Management Co., Ltd. Use of a cholinesterase inhibitor for the treatment of dementia and cognitive impairments

Also Published As

Publication number Publication date
WO2007107785A2 (en) 2007-09-27
WO2007107785A3 (en) 2008-01-10

Similar Documents

Publication Publication Date Title
EP2639317A3 (en) Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
NZ593628A (en) Genetic variants useful for risk assessment of thyroid cancer using rs944289
GEP20146107B (en) Method of identifying disease risk factors
WO2009055597A3 (en) Methods for identifying genetic linkage
ATE450547T1 (en) EML4-ALK FUSION GENE
WO2001090419A3 (en) Methods for genetic analysis of dna to detect sequence variances
ATE440969T1 (en) METHOD FOR DETECTING ANAPLASTIC THYROID CANCER AND METHOD FOR SUPPRESSING IT
NZ587903A (en) Susceptibility for lung cancer using the polymorphic marker rs1051730
NZ596070A (en) Genetic variants contributing to risk of prostate cancer
DE60335245D1 (en) METHOD AND NUCLEIC ACIDS FOR ANALYSIS OF COLONY CANCER
DE602007011301D1 (en) PROCEDURE FOR IDENTIFYING MUTANT ALLELES COMBINING REAL-TIME PCR AND REMS-PCR
ATE491809T1 (en) AMPLIFICATION OF DNA FRAGMENTS
PL1673473T3 (en) Use of genetic polymorphisms that associate with efficacy of treatment of inflammatory disease
MX2007008984A (en) Cancer markers and detection methods.
WO2003014388A3 (en) Method and nucleic acids for the analysis of colon cancer
MX2009004382A (en) Genetic variations associated with tumors.
WO2007076143A3 (en) Species-specific primer sets and identification of species-specific dna sequences using genome fragment enrichment
WO2009065511A3 (en) Methods and nucleic acids for the analysis of gene expression associated with the development of prostate cell proliferative disorders
NZ586431A (en) Genetic variants on chr hq and 6q as markers for prostate and colorectal cancer predisposition
WO2009117547A3 (en) Markers and methods for assessing and treating severe or persistant asthma
GB0605544D0 (en) Genetic Markers For Alzheimer Disease
RU2010149949A (en) TEST SYSTEM FOR DETERMINATION OF MUTATIONS IN HUMAN FUMARILACETOACETETATES AND HUMAN ALPHA-1-ANTITRIPSIN GENES
WO2010039189A3 (en) Methods for sequencing degraded or modified nucleic acids
WO2011128646A3 (en) Genetic markers for paget's disease
WO2006133866A3 (en) Prognostic markers for prediction of treatment response and/or survival of breast cell proliferative disorder patients

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)